Genetically engineered salmon has reached the dinner table, as AquaBounty Technologies, a Massachusetts company has successfully developed and commercialized a genetic variant of salmon fish, Salmo salar. The company announced that it has sold some 4.5 tonnes of its hotly debated product to customers in Canada. This...
Find MoreJason Sheltzer, a cancer biologist at Cold Spring Harbor Laboratory in New York, was on the hunt for genes involved in tumour growth. He and his colleagues planned to disable the MELK gene using the popular gene-editing tool CRISPR–Cas9, then look for changes that reduced the rate at which cancer cells multiply. The...
Find MoreLightweight sneakers, energy bars, high protein cereals, electrolyte cocktails- all of these promise the performance of a star athlete but rarely do the customers get even close to the peak level performance of those athletes. Even though billions are spent in sales, there is no satisfying example of performance thr...
Find MoreOn 11 February, researchers announced that they had finally sensed the ripples in the structure of space-time known as gravitational waves — capping a decades-long quest. A tumultuous US presidential campaign ended in a surprise victory for Republican businessman Donald Trump in November. Researchers struggled ...
Find MoreFabián Díaz achieved a milestone last year when he derived the first human embryonic stem-cell line from cells of Mexican origin. Biologists across Mexico now use the stem cells, which Díaz — a researcher at the National Institute of Perinatology in Mexico City — created using embryos discarded by a fertility clinic...
Find MoreThe American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.